Navigation Links
Most heart attack patients' cholesterol levels did not indicate cardiac risk
Date:1/12/2009

A new national study has shown that nearly 75 percent of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event, according to current national cholesterol guidelines.

Specifically, these patients had low-density lipoprotein (LDL) cholesterol levels that met current guidelines, and close to half had LDL levels classified in guidelines as optimal (less than 100 mg/dL).

"Almost 75 percent of heart attack patients fell within recommended targets for LDL cholesterol, demonstrating that the current guidelines may not be low enough to cut heart attack risk in most who could benefit," said Dr. Gregg C. Fonarow, Eliot Corday Professor of Cardiovascular Medicine and Science at the David Geffen School of Medicine at UCLA and the study's principal investigator.

While the risk of cardiovascular events increases substantially with LDL levels above 40󈞨 mg/dL, current national cholesterol guidelines consider LDL levels less than 100� mg/dL acceptable for many individuals. The guidelines are thus not effectively identifying the majority of individuals who will develop fatal and non-fatal cardiovascular events, according to the study's authors.

Researchers also found that more than half of patients hospitalized for a heart attack had poor high-density lipoprotein (HDL) cholesterol levels, according to national guidelines.

Published in the January issue of the American Heart Journal, the study suggests that lowering guideline targets for LDL cholesterol for those at risk for cardiovascular disease, as well as developing better treatments to raise HDL cholesterol, may help reduce the number of patients hospitalized for heart attack in the future.

"The study gives us new insight and intervention ideas to help reduce the number of heart attacks," said Fonarow, who is also director of the AhmansonUCLA Cardiomyop
'/>"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Heart Hospital of Austin First in World to Use New Device for Blocked Arteries
2. WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
3. Mortality rates higher for heart disease patients in poorer B.C. neighborhoods
4. CVBT Opens Two Additional Sites for Its ACORD Phase II Heart Trial
5. Heart Drug May Be a Cancer Fighter
6. Traditional risk assessment tools do not accurately predict coronary heart disease
7. New SMHEART LINK(TM) Technology Allows iPhones to Double as Fitness Monitors
8. Randy Jackson and the American Heart Association Encourage Philadelphia Residents to Get In The K.N.O.W. About Improving Type 2 Diabetes Management
9. New appropriate use criteria guide treatment of patients with heart blockage
10. Viagra May Shield Heart From Blood Pressure Damage
11. New hope for cancer comes straight from the heart

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Businesses of all sizes lookin...for the H1N1 pandemic have a new resource at their... (PRWEB) November 9, 2009 -- Human resource (HR) p...d response efforts for the H1N1 pandemic have a ne...nnesota’s Center for Infectious Disease Rese...
(Date:11/9/2009)... House Delivers on Election Promise. Now Is Time f...wire-USNewswire/ -- The following is a statement b...enerations of struggle and decades of delay, the U...t -- and, to pass historic reform legislation to a... access to high quality, affordable health care. T...
(Date:11/9/2009)...RIVERWOODS, Ill., Nov. 9 The House...ealth Care for America Act , which passed by a vot...tes several significant changes to the tax code an...ely to appear in any Senate version, requiring ext...H has issued a Special Tax Briefing on the tax...
(Date:11/9/2009)...WASHINGTON, Nov. 9 The Churchill...s Award For Leadership to J.W. "Bill" Marriott for...rough progressive free market practices and foster...e. Mr. Marriott will receive his award at a ceremo...ngton D.C. Four Seasons Hotel. ,, "This is a t...
(Date:11/9/2009)...in mice reports success with drugs that inhibit es...ews) -- Two drugs used to treat breast cancer and ...ccording to a new study. , The drugs also clear...and prevented the onset of cancer in mice with pre...vestrant and the breast cancer/osteoporosis drug r...
Breaking Medicine News(10 mins):Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2
... disease that can have Complication as its other n...could have, the dreaded would be the foot ulcer, a...n. For diabetics with this dreaded foot ulcer, ... healing of foot ulcers. People with diabetes m...
...are being developed on a daily basis. One of these...nt of those suffering from a degenerative eye cond...sels to grow underneath the retina and leak fluid,...of damaging the retinal tissue. This is a two-s...
...l companies hope to strike a pot of gold by making... war that is likely to escalate in coming days. ...panies to develop anti-AIDS drugs and market it in... entry of four more pharmaceutical companies inclu...
...ing the worst forms of nightmare over the past 3 w... but the threat of malaria . Malaria , not a ... tribal areas of Munger, 200 km (125 miles) southe...id the state's health minister Mr.Shakuni Choudhar...
... the recent issue of the American Journal of Epide...elp protect against a hip fracture. According to D...al, Glostrup, Denmark, and colleagues, when people... hip fractures. In the study, they found tha...
...ministration (FDA) at a conference in Washington, ...ts kind that directly removes the sign of a protei...eatment for chronic myelogenous leukemia (CML). ...rectly cause the disease. Gleevec, was discover...
Other Medicine News:
(Date:11/9/2009).../ -- Volcano Corporation (Nasdaq: VOLC ), a leade...ducts for the diagnosis and treatment of coronary ...will be participating in the Third Annual Canaccor...0. ,, The presentation by Scott Huennekens, pre...1 p.m., Pacific Standard Time (4 p.m., Eastern Sta...
(Date:11/9/2009)...tCall/ -- Cardiac Science Corporation (Nasdaq:...fibrillator ( AED ) and diagnostic cardiac monit...llion for the third quarter ended September 30, 20...y also recorded a charge of $18.5 million for an A...44.0 million to increase its valuation allowance a...
(Date:11/9/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...8th annual Global Congress for Minimally Invasive ...in Orlando, Florida. Results from two clinical st...ology/Gynecology products, including pelvic floor ...ems used to treat pelvic floor vaginal wall prolap...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5New research 3A Consumption of sugar substitutes assists in long term weight control 55125 1New research 3A Consumption of sugar substitutes assists in long term weight control 55125 2When cells run out of fuel 9677 1When cells run out of fuel 9677 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 1Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 3
...07 - Hemispherx Biopharma,Inc. (AMEX: HEB) announ...l of Immunology, April 2007) that explains the uni...rimental therapeutic,Ampligen(R) (Poly I : Poly C...notherapy for Chronic Fatigue Syndrome and as an,a...-reviewed study shows conclusively that the biolog...
...frontera AG announced,that an interim report regar...eratosis was received today from an independent re... investigate the,efficacy and safety of several do...ments received today refer to the clinical results... about the results,after twelve weeks will follow....
Other Medicine Technology:New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
Nova Epi-fluorescence
...are the hallmark of these stereozoom fluorescent m...n mind. The top (incident) circular 9W fluorescent...inating shadows while remaining cool to the touch....e with 10x to 44x zoom magnification or high-power...
...vative and efficient inverted routine microscope. ...cility. Improved mechanics and increased stability...cular and TS100-F trinocular models. The TS100-F t...ts Nikon's FX-III series photomicrographic systems...
...system utilizes an evanescent wave to excite singl...e coverglass. Extendable "stratum structure". This...th TIRF and epi-fluorescence illumination systems,...ies. It also allows their dedicated filters to be ...
Medicine Products: